Hester Biosciences Ltd.

NSE: HESTERBIO  SECTOR: Pharmaceuticals & Drugs

2260.85
-88.6 (-3.77%)

Price Summary

Today's High

₹ 2379

Today's Low

₹ 2180

52 Week High

₹ 2401.45

52 Week Low

₹ 981.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

1923.274573525 Cr.

Enterprise Value

1965.981320525 Cr.

No. of Shares

0.8506865 Cr.

P/E

53.36

P/B

8.41

Face Value

₹ 10

Div. Yield

0.29%

Book Value (TTM)

₹  268.7828

CASH

5.1895092 Cr.

DEBT

47.8962562 Cr.

Promoter Holding

53.73%

EPS (TTM)

₹  42.3693

Sales Growth

-1.02888631613329%

ROE

16.3254204088218 %

ROCE

19.7406120956449 %

Profit Growth

18.4292044074751 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year-1.03%
3 Year11.18%
5 Year13.48%

Profit Growth (in Cr.)

1 Year-28.8%
3 Year7.78%
5 Year17.41%

ROE%

1 Year16.33%
3 Year22.02%
5 Year21.86%

ROCE %

1 Year19.74%
3 Year25.72%
5 Year24.62%

Debt/Equity

0.235848826176315

Price to Cash Flow

72.76

Interest Cover Ratio

9.1900819500087

CFO/PAT (5 Yr. Avg.)

0.960591671827093

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2021 53.73 0
Dec 2020 53.73 0
Sep 2020 53.73 0
Jun 2020 53.73 0
Mar 2020 53.73 0
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 22.0196819901852% over the past 3 years.
  • Company has been maintaining healthy ROCE of 25.7233958314503% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 9.1900819500087.
  • The Company has been maintaining an effective average operating margins of 34.5008149793891% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 2.16584366105373.
  • The company has a high promoter holding of 53.73%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 10.1385069259238.

 Limitations

  • The company has shown a poor profit growth of 7.77784526342777% for the Past 3 years.
  • The company has shown a poor revenue growth of 11.179203321121% for the Past 3 years.
  • Company has contingent liabilities of 49.810158 Cr.
  • The company is trading at a high EV/EBITDA of 30.9769.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
Net Sales 43.39 41.43 38.88 53.62 52.82
Total Expenditure 30.39 31.17 25.56 36.15 32.23
Operating Profit 13.01 10.27 13.32 17.48 20.58
Other Income 1.46 0.3 0.42 0.48 0.64
Interest 1.41 1.78 0.96 1.57 0.94
Depreciation 2.45 2.29 2.36 2.39 2.44
Exceptional Items 0 0 0 0 0
Profit Before Tax 10.61 6.5 10.41 13.99 17.85
Tax 2.88 1.5 2.79 3.86 4.55
Profit After Tax 7.73 5 7.62 10.13 13.29
Adjusted EPS (Rs) 0.91 0.59 0.9 1.19 1.56

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 100.89 123.28 134.79 171.19 169.43
Total Expenditure 67.5 82.21 85.19 103.42 116.7
Operating Profit 33.39 41.08 49.6 67.76 52.72
Other Income 0.87 0.73 1.88 3.1 2.93
Interest 3.69 3.21 2.32 3.54 5.03
Depreciation 5.73 5.51 5.45 7.57 9.38
Exceptional Items 0 0 0 0 0
Profit Before Tax 24.85 33.09 43.71 59.75 41.23
Tax 5.63 8.15 13.15 15.9 10
Net Profit 19.22 24.94 30.56 43.85 31.22
Adjusted EPS (Rs.) 22.6 29.32 35.92 51.55 36.7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 8.51 8.51 8.51 8.51 8.51
Total Reserves 91.81 113.58 137.57 170.93 194.57
Borrowings 12.87 18.66 14.61 11.37 7.45
Other N/C liabilities 8.18 3.7 7.37 10.14 8.44
Current liabilities 37.45 33.99 42.43 39.3 56.1
Total Liabilities 158.82 178.44 210.49 240.24 275.06
Assets
Net Block 61.57 60.85 66.74 100.81 96.76
Capital WIP 10.47 21.29 30.47 0.42 0.87
Investments 8.67 8.6 14.48 28.22 40.67
Loans & Advances 10.93 12.41 9.59 9.81 11.39
Other N/C Assets 0 0.47 0.08 1.58 3.87
Current Assets 67.18 74.81 89.13 99.4 121.5
Total Assets 158.82 178.44 210.49 240.24 275.06
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 24.85 33.09 43.71 59.75 41.23
Adjustment 9.31 8.74 7.34 8.5 11.24
Working Capital Changes -9.54 -7.22 -9.37 -16.47 -15.41
Tax Paid -5.97 -7.06 -9.39 -15.58 -10.62
Operating Cash Flow 18.64 27.55 32.28 36.19 26.43
Investing Cash Flow -5.68 -15.49 -26.32 -24.7 -18.51
Financing Cash Flow -11.92 -5.6 -6.24 -20.29 -5.27
Net Cash Flow 1.04 6.46 -0.28 -8.8 2.65

Corporate Actions

Company News

Hester Biosciences Stock Price Analysis and Quick Research Report. Is Hester Biosciences an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Hester Biosciences and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 26.4321049 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Hester Biosciences has a Debt to Equity ratio of 0.235848826176315 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Hester Biosciences , the EPS growth was -28.7975929744651 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Hester Biosciences has OPM of 31.1172869759681 % which is a good sign for profitability.
     
  • ROE: Hester Biosciences have a average ROE of 16.3254204088218 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Hester Biosciences

X